BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
23.12.25
/
50%
€51.44
Target price
23.12.26
€84.93
Performance (%)
0.82%
Price
23.12.25
€51.86
Summary
This prediction is currently active. Since the start of the prediction for BioMarin Pharmaceutical Inc. the price has only changed by 0.82%. This prediction currently runs until 23.12.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | 0.82% |
| iShares Core DAX® | 0.765% |
| iShares Nasdaq 100 | 1.418% |
| iShares Nikkei 225® | 0.658% |
| iShares S&P 500 | 1.310% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target raised by analysts at Truist Financial Corporation from $80.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.07
28.10.25
28.10.25
€68.62
28.10.26
28.10.26
12.57%
23.12.25
23.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.04
17.09.24
17.09.24
€80.92
17.09.25
17.09.25
-27.97%
18.09.25
18.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€106.35
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-24.36%
26.09.24
26.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.68
15.09.23
15.09.23
€131.12
15.09.24
15.09.24
-8.81%
16.09.24
16.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
3.31%
14.07.24
14.07.24

